Dr.Long Pang |Oncology Pharmaceuticals| Best Researcher Award-1332

Published on by Top Pharmaceutical

Dr.Long Pang|Oncology Pharmaceuticals |Best Researcher Award|

Dr.Long Pang at Xi’an Medical University, China

PROFILE  

scopus

Early Academic Pursuits 📚

Long Pang was born in Gansu, China, where he developed an early passion for science and innovation. His academic journey began with a focus on veterinary science, where he pursued a Master of Science (M.S.) degree at Northwest Agricultural and Forestry University in Yangling, Shaanxi, China. Completing his M.S. in July 2012, Pang demonstrated an exceptional commitment to his studies and research in veterinary science, laying the groundwork for his future endeavors in animal biotechnology. In August 2012, he advanced his academic career by enrolling in a Ph.D. program at the same university. During his Ph.D. studies, he specialized in Animal Biotechnology, a field that encompasses the use of biotechnological tools for the improvement of animal health and productivity. He completed his Ph.D. in July 2016, marking the beginning of a promising career in biomedical research.

Professional Endeavors 🏢

After earning his Ph.D., Long Pang joined Xi’an Medical University as an Associate Professor in the School of Basic Medical Science. His professional career is distinguished by his innovative research in the areas of microfluidics and single-cell analysis. At Xi’an Medical University, Pang quickly established himself as a leading researcher, focusing on the development of microfluidic chips and their applications in single-cell analysis and organ-on-a-chip technology. His work has been instrumental in advancing the understanding of cellular mechanics and tumor microenvironments, contributing significantly to the fields of biomedical engineering and cancer research.

Contributions and Research Focus 🔬

Long Pang’s research primarily revolves around microfluidics-based single-cell analysis and organ-on-a-chip technologies. His work has led to the development of innovative microfluidic devices that allow for the manipulation and analysis of single cells in a highly controlled environment. These devices have broad applications in cancer research, particularly in studying tumor microenvironments and the behavior of cancer stem cells. One of his significant contributions includes the development of a microfluidic chip for glioma stem cell sorting and single-cell-derived tumor sphere assays. This research has provided valuable insights into the formation of tumor spheres and the role of the tumor microenvironment in cancer progression.

Pang has also been involved in projects aimed at integrating microfluidic platforms with other technologies to enhance the precision and efficiency of single-cell analysis. His research has been supported by several prestigious grants, including those from the National Science Foundation of China and the Fundamental Research Foundation of Xi’an Medical University. Notably, he has led projects such as the study of heterotypic single-cell-derived tumor-sphere formation using an integrated microfluidics platform, which has garnered significant attention and funding.

Accolades and Recognition 🏆

Long Pang’s contributions to the field of biomedical research have been widely recognized. His work has resulted in over 21 publications in high-impact journals, including TRAC-Trends in Analytical Chemistry, Analytical Chemistry, and Sensors & Actuators B: Chemical. He has also authored a chapter in the Handbook of Single-Cell Technologies, published by Springer, highlighting his expertise in digital microfluidics for single-cell manipulation and analysis. In addition to his publications, Pang has been granted two Chinese patents related to his innovations in microfluidic technology, further establishing his reputation as a leading researcher in his field.

Pang’s achievements have also been acknowledged through various editorial appointments. He has served as a Youth Editorial Board Member of Glioma and the E-Journal of Translational Medicine, where he has contributed to the advancement of research dissemination and knowledge sharing in the scientific community. His contributions to the academic community extend beyond research, as he is an active member of several professional organizations, including the Shaanxi Pharmacology Association, the Chinese Society of Micro-Nano Technology (CSMNT), and the Chinese Chemistry Society (CCS).

Impact and Influence 🌍

The impact of Long Pang’s research extends beyond academia. His work on microfluidic devices has the potential to revolutionize the way single-cell analysis is conducted, offering new tools for researchers and clinicians in the diagnosis and treatment of diseases, particularly cancer. His contributions to the development of organ-on-a-chip technology are also significant, providing a platform for more accurate and efficient drug testing, which could lead to more effective treatments for various diseases.

Pang’s research has influenced a new generation of scientists and engineers, inspiring them to explore the possibilities of microfluidics and its applications in biomedical research. His collaborations with other leading researchers and institutions, both in China and internationally, have further expanded the reach of his work, fostering innovation and knowledge exchange in the global scientific community.

Legacy and Future Contributions 🚀

Long Pang’s legacy in the field of biomedical research is characterized by his innovative approach to solving complex problems in cell biology and medicine. His contributions to the development of microfluidic technology and single-cell analysis tools have set new standards in the field, paving the way for future research and innovation. As he continues his work at Xi’an Medical University, Pang remains committed to advancing the frontiers of biomedical engineering, with a focus on developing new technologies that can improve human health and well-being.

Looking to the future, Long Pang’s ongoing research projects, such as the construction of a 3D microenvironment for single-cell level tumor cells, promise to yield further breakthroughs in our understanding of cancer and other diseases. His work is likely to continue to influence the field for years to come, as he mentors the next generation of researchers and contributes to the global effort to improve healthcare through technological innovation.

🎓Publication 

Tumor microenvironment-derived exosomes-assisted single-cell-derived tumor-sphere formation and drug-resistance by a microfluidic system

Construction of multiple concentration gradients for single-cell level drug screening

Droplets microfluidics platform—A tool for single cell research

Microfluidics-Based Single-Cell Research for Intercellular Interaction

Digital Microfluidics for Single Cell Manipulation and Analysis

  • Authors   :Pang, L., Ding, J., Fan, S.-K.
  • Journal    :Handbook of Single-Cell Technologies
  • Year         :2021

D. Mina Kiani |Endocrine Pharmacology| Best Researcher Award

Published on by Top Pharmaceutical

D. Mina Kiani|Endocrine Pharmacology |Best Researcher Award|

D. Mina Kiani at Arak university, Iran

PROFILE  

scopus

Early Academic Pursuits 🎓

Mina Kiani’s academic journey began with a deep passion for the biological sciences, particularly in understanding the intricate processes that govern cell biology and development. She pursued her Bachelor’s degree in Biology at a reputable university in Iran, where she developed a solid foundation in the life sciences. Eager to delve deeper into the complexities of human biology, she continued her education by obtaining a Master’s degree in Histology and Embryology from Razi University of Kermanshah. Her master’s thesis, which focused on the histological changes in embryonic development, showcased her keen interest in developmental biology and set the stage for her future research endeavors.

Driven by a desire to contribute to the scientific community, Mina Kiani pursued a Ph.D. in Cell Biology and Development at Arak University. During her doctoral studies, she embarked on a pioneering research project that explored the effects of the antidiabetic drug empagliflozin on the reproductive system of diabetic rats. This research was particularly significant as it addressed a previously unexplored area of study, highlighting her innovative approach to scientific research.

Professional Endeavors 🧪

After completing her Ph.D., Mina Kiani joined the faculty at Arak University as a lecturer, where she has since been dedicated to both teaching and research. Her role as an educator has allowed her to share her expertise in cell biology, histology, and embryology with the next generation of scientists. Kiani is highly regarded by her students for her ability to simplify complex concepts and her commitment to fostering a deep understanding of biological sciences.

In addition to her teaching responsibilities, Kiani has been actively involved in research. Her work primarily focuses on pharmacokinetics, endocrine pharmacology, and drug safety, with a particular interest in how various drugs affect reproductive health. Her research has led to significant findings in the field, particularly concerning the impact of empagliflozin on testicular tissue and sperm parameters in diabetic rats.

Contributions and Research Focus 🔬

Mina Kiani’s contributions to the field of pharmacology and reproductive biology are both profound and innovative. Her research on empagliflozin, a relatively new antidiabetic drug, has been groundbreaking. Recognizing the increasing prevalence of type 2 diabetes among young men, Kiani sought to understand how this drug affects male reproductive health—a critical area that had not been previously studied.

Her research revealed that empagliflozin has antioxidant, anti-apoptotic, and anti-inflammatory effects on the testicular tissue of diabetic rats. These findings are crucial as they suggest that the drug may mitigate some of the harmful effects of diabetes on male fertility, potentially offering new therapeutic avenues for patients. Kiani’s work has been published in the prestigious journal Biochemical Pharmacology, where her study, “Empagliflozin reduces the adverse effects of diabetes mellitus on testicular tissue in type 2 diabetic Rats: A stereological and biochemical study,” has garnered attention for its scientific rigor and clinical relevance.

Accolades and Recognition 🏆

Mina Kiani’s work has not gone unnoticed in the scientific community. Her innovative research on the effects of empagliflozin has earned her recognition as a leading researcher in her field. The publication of her study in a high-impact journal is a testament to the quality and significance of her research. Moreover, her dedication to teaching and her ability to inspire students have made her a respected figure at Arak University.

While Kiani has not yet received formal awards for her work, the impact of her research is evident in the scientific community’s response to her publications. Her study on empagliflozin has been cited by other researchers, further validating the importance of her findings.

Impact and Influence 🌍

Mina Kiani’s research has the potential to influence clinical practices related to the treatment of diabetes in young men. By shedding light on the effects of empagliflozin on reproductive health, her work could lead to more informed decisions regarding the prescription of this drug to diabetic patients, particularly those concerned with fertility. Additionally, her research contributes to a broader understanding of the relationship between diabetes and reproductive health, an area that is becoming increasingly important as the prevalence of diabetes continues to rise globally.

As an educator, Kiani has also made a significant impact on her students, many of whom have gone on to pursue careers in the biological sciences. Her ability to connect with students and her dedication to their academic and professional development have helped shape the next generation of researchers and healthcare professionals.

Legacy and Future Contributions 🌟

Mina Kiani’s legacy is one of innovation, dedication, and a commitment to advancing our understanding of pharmacology and reproductive health. Her pioneering research on empagliflozin has opened new avenues for exploration and has the potential to improve the lives of countless individuals living with diabetes. As she continues her research, Kiani is likely to make further contributions to the field, particularly in understanding how other antidiabetic drugs affect reproductive health.

Looking ahead, Kiani is poised to continue her work at the intersection of pharmacology and reproductive biology. She plans to expand her research to include studies on the long-term effects of empagliflozin and other antidiabetic drugs on reproductive health. Additionally, she aims to collaborate with other researchers and institutions to further explore the complex relationships between diabetes, pharmacology, and fertility.

🎓Publication 

Empagliflozin reduces the adverse effects of diabetes mellitus on testicular tissue in type 2 diabetic Rats: A stereological and biochemical study

  • Authors   :Kiani, M., Soleimani Mehranjani, M., Ali Shariatzadeh, M.
  • Journal    :Biochemical Pharmacology
  • Year         :2024

Sildenafil citrate ameliorates the adverse effects of cryopreservation on sperm quality in asthenozoospermic men

  • Authors   :Kohzadi, R., Cheraghi, E., Mehranjani, M.S., Shariatzadeh, M.
  • Journal    :Healthcare Materials
  • Year         :2024

Seamless Integration of Rapid Separation and Ultrasensitive Detection for Complex Biological Samples Using Multistage Annular Functionalized Carbon Nanotube Arrays

  • Authors   :Lihuang Li; Jialing Zhang; Zhengqi Jiao; Xi Zhou; Lei Ren; Miao Wang.
  • Journal    :Cryobiology
  • Year         :2023

The effect of platelet lysate on mouse ovarian structure, function and epigenetic modifications after autotransplantation

  • Authors   :Sanamiri, K., Soleimani Mehranjani, M., Shahhoseini, M., Shariatzadeh, S.M.A.
  • Journal    :Reproductive BioMedicine Online
  • Year         :2023

The therapeutic effect of co-administration of pentoxifylline and zinc in men with idiopathic infertility

Prof. Lei Ren |Drug Delivery Systems| Best Researcher Award-1331

Published on by Top Pharmaceutical

Prof. Lei Ren|Drug Delivery Systems |Best Researcher Award|

Prof. Lei Ren at mus alparslan university, Turkeys

PROFILE  

Orcid 

Early Academic Pursuits 📚

Lei Ren’s academic journey began in the vibrant city of Tianjin, where she pursued her Bachelor of Science in Material Science & Engineering at Tianjin University, graduating in 1990. This foundational period was marked by her strong dedication to understanding the principles of material science, a field that would later shape her illustrious career. Tianjin University’s rigorous curriculum provided Ren with a solid grounding in the fundamentals of material science, equipping her with the skills and knowledge to explore its applications in various domains.

Ren’s academic curiosity led her to pursue further education at Peking Union Medical College, one of China’s most prestigious institutions. In 1997, she earned her Master of Science in Biomedical Engineering, a field that bridged her interests in material science and its applications in medicine. This interdisciplinary approach was a hallmark of Ren’s early academic endeavors, reflecting her passion for integrating diverse fields of study to address complex scientific challenges.

Her pursuit of knowledge did not stop there. Ren continued her academic journey in Japan, where she completed her Ph.D. in Material Science at Okayama University in 2001. This period was crucial in shaping her research trajectory, as she delved into advanced materials and their potential biomedical applications. Her time in Japan also exposed her to a new scientific culture, broadening her perspective and fostering a global approach to research that would later define her career.

Professional Endeavors 🌟

Upon completing her doctoral studies, Ren embarked on a career that seamlessly blended research and academia. Her first professional role was as a Research Associate at the Institute of Biomedical Engineering, Chinese Academy of Medical Sciences, where she worked from 1990 to 1997. During this time, Ren honed her research skills, contributing to various projects that explored the interface between material science and biomedical engineering.

In 2001, Ren transitioned to a global stage, joining the Singapore-MIT Alliance at the National University of Singapore as a Research Fellow. This opportunity allowed her to collaborate with leading scientists from around the world, further enhancing her research capabilities and expanding her professional network. Her work during this period focused on cutting-edge biomedical engineering projects, laying the groundwork for her future contributions to the field.

In 2002, Ren returned to China to join the Research Center of Biomedical Engineering at the College of Medicine, Xiamen University, as an Associate Professor. Over the next five years, she played a pivotal role in advancing the center’s research agenda, mentoring students, and publishing influential papers. Her dedication and expertise earned her a promotion to full Professor in 2007, a position she holds to this day at the Department of Biomaterials, College of Materials, Xiamen University.

Contributions and Research Focus 🧬

Ren’s research has primarily focused on the development and application of biomaterials, particularly in the context of biomedical engineering. Her work has explored the synthesis and characterization of novel materials designed to interact with biological systems, with the goal of improving medical devices, implants, and tissue engineering applications.

One of her significant contributions to the field has been her research on biocompatible materials that can be used in medical implants. Ren’s work has helped advance the understanding of how materials interact with the human body, leading to the development of safer and more effective implants that reduce the risk of rejection and improve patient outcomes. Her research has also explored the use of biomaterials in tissue engineering, where she has contributed to the development of scaffolds that support the growth and regeneration of tissues.

In addition to her work on biomaterials, Ren has also been involved in interdisciplinary projects that integrate material science with other fields, such as nanotechnology and regenerative medicine. Her ability to bridge these diverse areas of study has positioned her as a leader in the field of biomedical engineering, with her work having a profound impact on both academic research and practical medical applications.

Accolades and Recognition 🏅

Throughout her career, Lei Ren has received numerous accolades in recognition of her contributions to the field of biomedical engineering. Her research has been widely published in leading scientific journals, earning her a reputation as a highly respected scholar in her field. Her work has also been recognized by various professional organizations, both in China and internationally, highlighting her status as a pioneering figure in the field of biomaterials.

Ren has been invited to speak at numerous international conferences, where she has shared her insights on the latest developments in biomaterials and biomedical engineering. These speaking engagements have not only showcased her research but also facilitated the exchange of ideas with other leading scientists, furthering the advancement of the field.

Impact and Influence 🌍

Ren’s influence extends beyond her research and academic roles. As a professor at Xiamen University, she has mentored numerous students who have gone on to make their own contributions to the field of biomedical engineering. Her commitment to teaching and mentorship has helped shape the next generation of scientists, ensuring that her impact will be felt for years to come.

Moreover, Ren’s work has had a tangible impact on the medical field. The biomaterials she has developed have been used in various medical devices and implants, improving the quality of life for patients around the world. Her interdisciplinary approach to research has also inspired new collaborations between scientists from different fields, leading to innovative solutions to some of the most pressing challenges in medicine.

Legacy and Future Contributions 🔮

As Lei Ren continues her work at Xiamen University, her legacy as a pioneer in the field of biomaterials is already well established. Her contributions to the development of biocompatible materials and her interdisciplinary approach to research have left an indelible mark on the field of biomedical engineering. Moving forward, Ren is likely to continue pushing the boundaries of what is possible in her field, exploring new frontiers in material science and its applications in medicine.

🎓Publication 

Oral biomimetic virus vaccine hydrogel for robust abscopal antitumour efficacy

  • Authors   :Chufan Wang; Haobo Tang; yufei Duan; Qiang Zhang; Wenjun Shan; Xiumin Wang; Lei Ren
  • Journal    :Colloid and Interface Science
  • Year         :2024

Tumor‐Associated Myeloid Cells Selective Delivery of a Therapeutic Tumor Nano‐Vaccine for Overcoming Immune Barriers for Effective and Long‐Term Cancer Immunotherapy

  • Authors   :Chufan Wang; Jinglian Zhao; Yufei Duan; Liping Lin; Qiang Zhang; Haiping Zheng; Wenjun Shan; Xiumin Wang; Lei Ren
  • Journal    :Healthcare Materials
  • Year         :2024

Seamless Integration of Rapid Separation and Ultrasensitive Detection for Complex Biological Samples Using Multistage Annular Functionalized Carbon Nanotube Arrays

  • Authors   :Lihuang Li; Jialing Zhang; Zhengqi Jiao; Xi Zhou; Lei Ren; Miao Wang.
  • Journal    :Materials
  • Year         :2024

Generalized Multifunctional Coating Strategies Based on Polyphenol-Amine-Inspired Chemistry and Layer-by-Layer Deposition for Blood Contact Catheters

  • Authors   :Jiahao Du; Xiaoting Zhang; Wenlong Li; Miao Wang; Xi Zhou; Lei Ren
  • Journal    :Biomaterials Science & Engineering
  • Year         :2024

Driving modes and characteristics of biomedical micro-robots

  • Authors   :Engineered Regeneration
    .

  • Journal    :Libing Huang; Yueyuan Pan; Miao Wang; Lei Ren
  • Year         :2023

Dr. Rahim Dehghan|Pharmaceutical Biotechnology| Best Researcher Award

Published on by Top Pharmaceutical

Dr. Rahim Dehghan|Pharmaceutical Biotechnology |Best Researcher Award|

Dr. Rahim Dehghan at mus alparslan university, Turkeys

PROFILE  

scopus

Google Sholar

 

Early Academic Pursuits 🎓

Rahim Dehghan embarked on his academic journey in the field of polymer engineering at Shiraz University, where he earned his bachelor’s degree in 2011. Driven by a deep curiosity and passion for polymer science, he pursued a master’s degree in polymer engineering at Yazd University, completing it in 2015. His master’s thesis was a significant exploration of blood-compatible membranes, a topic that laid the foundation for his future research endeavors. This period of academic training provided him with a robust understanding of polymer materials and their applications in biomedical engineering, particularly in the development of membranes for medical use.

Professional Endeavors and Research Focus 🧪

Dehghan’s professional career has been marked by a series of research positions and projects that have focused on the development and enhancement of synthetic membranes for biomedical applications. In 2016, he commenced his Ph.D. at the prestigious Iran Polymer and Petrochemical Institute, a leading center for polymer education in Iran. His doctoral research was centered on developing membranes for the separation of low-density lipoprotein (LDL), commonly known as bad cholesterol, from blood plasma. This work was groundbreaking, as it addressed critical challenges in blood purification technologies, aiming to improve the efficiency and efficacy of these processes.

During his Ph.D. studies, Dehghan worked on several key aspects of membrane engineering, including pore size optimization, morphology control, and enhancing membrane permeability. His innovative approach to membrane structural engineering was aimed at achieving high-performance membranes capable of selective separation of LDL from blood plasma, while ensuring high plasma permeability. His research contributions during this period culminated in a Ph.D. degree, awarded in 2022 with an excellent grade, reflecting the significance and quality of his work.

Contributions and Research Focus 🌍

Dehghan’s research has had a profound impact on the field of membrane science, particularly in the development of membranes for biomedical applications. His work on LDL separation has opened new avenues for research in blood purification technologies, with potential applications in treating cardiovascular diseases and other conditions where blood purification is critical. He has also contributed to the field of microfiltration membranes for plasmapheresis, a process used to separate plasma from blood cells. His recent work has successfully developed a microfiltration membrane capable of simultaneously separating LDL and blood cells from whole blood, a significant advancement in this area.

In addition to his academic research, Dehghan has played a crucial role in the industrial application of his findings. As a researcher at the Iranian Polymer and Petrochemical Institute and a senior researcher at D.G.DENA Co., he has applied his expertise to the development of biomedical devices, including hydrogels and gels for wound care. His work in these roles has involved the application of advanced polymer science to address real-world challenges in medical device manufacturing.

Accolades and Recognition 🏆

Throughout his academic and professional career, Dehghan has received numerous accolades that highlight his contributions to the field of polymer engineering. One of his early achievements was acquiring the 8th rank in the national Ph.D. entrance exam in Iran in 2016, a highly competitive examination with over 400 participants. This accomplishment not only earned him a prestigious scientific award but also set the stage for his successful academic career.

His research has been widely recognized and published in several leading international journals, including the Journal of Membrane Science and Separation and Purification Technology. These publications have not only disseminated his findings to the broader scientific community but have also established him as a leading researcher in the field of polymer-based membrane technologies.

Impact and Influence 🌟

Dehghan’s work has had a significant impact on both the academic and industrial sectors. His research on membrane technologies has provided new insights into the design and development of high-performance membranes for medical applications. These contributions are particularly important in the context of blood purification technologies, where efficient and selective separation processes are critical for patient outcomes.

In the industrial sphere, his work as a consultant and researcher has directly influenced the development of new medical devices, particularly in the area of wound care. His expertise in polymer science has been instrumental in advancing the capabilities of these devices, ensuring they meet the stringent requirements of biomedical applications.

Legacy and Future Contributions 🌠

Looking ahead, Rahim Dehghan’s contributions to the field of polymer engineering and membrane science are poised to leave a lasting legacy. His work has already set new standards for the development of synthetic membranes, particularly in the biomedical field. As he continues to explore new research opportunities, particularly in the field of blood purification membranes such as hemodialysis and hemodiafiltration, his impact on the field is expected to grow.

🎓Publication 

Dextran sulfate bulk and surface-modified microfiltration membrane for simultaneous blood plasma harvesting and low-density lipoprotein removal during plasmapheresis

  • Authors   :Dehghan, R., Barzin, J., Carbonell, R.G., Ghaderi Jafarbeigloo, H., Kordkatooli, Z.
  • Journal    :Journal of Membrane Science
  • Year         :2024

Evaluation of solubility parameters and relative energy difference (RED) on the preparation of polysulfone/polyethylene glycol membrane: A study on the casting solution and coagulation bath

Membrane patterning through horizontally aligned microchannels developed by sulfated chopped carbon fiber for facile permeability of blood plasma components in low-density lipoprotein apheresis

High cut-off membrane: evaluation of pore collapse and the synergistic effect of low and high molecular weight polyvinylpyrrolidone

Low density lipoprotein (LDL) apheresis from blood plasma via anti-biofouling tuned membrane incorporated with graphene oxide-modified carrageenan

Assist Prof Dr. AYŞEGÜL KILIÇLI|Clinical Trials| Best Researcher Award

Published on by Top Pharmaceutical

Assist Prof Dr. AYŞEGÜL KILIÇLI|Clinical Trials |Best Researcher Award|

Assist Prof Dr. AYŞEGÜL KILIÇLI at mus alparslan university, Turkeys

PROFILE  

scopus

Orcid

 

Early Academic Pursuits 🎓

Assist. Prof. Dr. Ayşegül KILIÇLI embarked on her academic journey with a profound dedication to the field of nursing, focusing specifically on obstetrics and gynecology. She earned her Bachelor’s degree in Nursing from a reputable institution, where her commitment to the healthcare field began to shine. Driven by a desire to enhance her expertise and contribute significantly to her field, she pursued a Master’s degree in Obstetric and Gynecology Nursing. This was followed by rigorous research and a doctoral degree (Ph.D.) in the same domain, equipping her with advanced knowledge and research skills essential for a successful academic and professional career.

Professional Endeavors 👩‍⚕️

Dr. KILIÇLI is currently serving as an Assistant Professor in the Obstetric and Gynecology Nursing Department at Muş Alparslan University Health Sciences Faculty. Her role involves teaching, mentoring, and guiding students through their academic and clinical experiences. Her professional journey reflects a commitment to advancing nursing education and practice. She is actively involved in several research projects and has published extensively in high-impact journals. Her work focuses on improving healthcare practices and patient outcomes, particularly in the field of obstetrics and gynecology.

Contributions and Research Focus 🔬

Dr. KILIÇLI’s research is primarily concentrated on obstetric and gynecology nursing. One of her notable completed research projects is a randomized controlled trial examining the effect of neurolinguistic programming and progressive muscle relaxation exercises on breastfeeding success and self-efficacy. This innovative study has been instrumental in advancing knowledge about non-pharmacological interventions in maternal care. Her research contributions are reflected in her publications in SCI-E journals, where her work is highly regarded by the scientific community.

Accolades and Recognition 🏆

Dr. KILIÇLI’s research excellence and contributions to the field have earned her recognition in various forums. Her work has been cited in prestigious databases, including Science Citation Index-Expanded (SCI-E), Scopus, and Web of Science (ESCI). She is celebrated for her significant contributions to advancing obstetric and gynecology nursing practices. Her role as a corresponding researcher further highlights her leadership and expertise in the field, establishing her as a respected figure in the global research community.

Impact and Influence 🌍

Dr. KILIÇLI’s impact extends beyond her research and academic contributions. Her work has positively influenced clinical practices, particularly in improving breastfeeding outcomes and maternal self-efficacy. By integrating innovative approaches into her research, she has contributed to the development of more effective strategies in nursing care. Her influence is also evident in the academic and professional growth of her students, who benefit from her extensive knowledge and mentorship.

Legacy and Future Contributions 🔮

As a pioneering researcher in obstetric and gynecology nursing, Dr. KILIÇLI is poised to leave a lasting legacy in her field. Her dedication to advancing maternal and child health through research and education is commendable. Looking ahead, Dr. KILIÇLI plans to continue her research with a focus on exploring new interventions and improving existing practices. Her future contributions are expected to further enhance nursing care practices and patient outcomes, reinforcing her position as a leading expert in her field.

🎓Publication 

The effect of neurolinguistic programming and progressive muscle relaxation exercises on breastfeeding success and breastfeeding self-efficacy: A randomized controlled trial

  • Authors   :Kiliçli, A., Gül, S.
  • Journal    :Explore
  • Year         :2024

Effect of Reflexology on Pain, Fatigue, Sleep Quality, and Lactation in Postpartum Primiparous Women After Cesarean Delivery: A Randomized Controlled Trial

Stress, Anxiety, and Postpartum Depression in Parents with Premature Infants in Neonatal Intensive Care Unit

Stigmatizing attitudes, beliefs, and actions of women towards abortion in rural regions with high fertility

Women’s reproductive behaviour and perspectives on fertility, and their modifying factors, in a Turkish province with a high fertility rate

Dr. Amrendra Ajay|Cardiovascular disease| Best Researcher Award

Published on by Top Pharmaceutical

Dr. Amrendra Ajay|Cardiovascular |Best Researcher Award|

Dr. Amrendra Ajay at Brigham and Women’s Hospital, Harvard, United States

PROFILE  

scopus

Orcid

 

Early Academic Pursuits 🎓

Amrendra Ajay’s academic journey began at B.N. College, Patna University, where he earned a Bachelor of Science degree in Biotechnology in 2002. His early focus on biotechnology laid a strong foundation for his future research endeavors. Eager to expand his knowledge, he pursued a Master of Science in Biotechnology at the prestigious Indian Institute of Technology (IIT), Bombay. The advanced curriculum and exposure to cutting-edge research during this period further fueled his interest in the field of biotechnology and biomedical sciences.

Ajay’s passion for research led him to the National Centre for Cell Science (NCCS) at Pune University, where he undertook his doctoral studies. His Ph.D. research centered on cancer biology, specifically focusing on chemotherapeutic drug-induced cell signaling in in vivo mouse models of cervical carcinoma. This research provided Ajay with a deep understanding of molecular biology and cancer research, setting the stage for his future work in kidney disease.

Professional Endeavors and Contributions 🧑‍🔬

Upon completing his Ph.D., Ajay transitioned to Harvard Medical School in Boston, where he embarked on a postdoctoral fellowship in 2010. His postdoctoral research was a pivotal period in his career, during which he delved into the mechanisms of acute kidney injury (AKI) and its progression to chronic kidney disease (CKD). This research was significant as it addressed a critical area in nephrology, focusing on how acute kidney injury could lead to long-term chronic conditions, a transition that was not fully understood at the time.

Ajay’s work involved the use of knockout mouse models to study molecular signaling pathways. He made significant contributions by showing how changes in molecular signaling could protect against acute kidney injury. One of his notable findings was the role of checkpoint kinase 1 (Chk1) in mediating the phosphorylation of STAT3, a transcription factor, which in turn regulated the expression of kidney injury molecule-1 (KIM-1), a key marker in kidney injury.

Since 2017, Ajay has held the position of Instructor in Medicine at Harvard Medical School and Associate Biologist at Brigham and Women’s Hospital. In these roles, he has continued his research on kidney diseases, focusing on the molecular mechanisms that drive the progression from acute to chronic kidney disease. His work has included the study of DPF3, an epigenetic regulator, and its role in chromatin remodeling and gene expression during kidney disease progression.

Research Focus and Impact 🔬

Ajay’s research has consistently aimed at unraveling the molecular underpinnings of kidney diseases, with a particular focus on the transition from acute kidney injury to chronic kidney disease. His work has identified several key molecular players, such as STAT3 and fibrinogen, which are involved in this progression. By understanding these mechanisms, Ajay’s research has opened new avenues for therapeutic interventions that could potentially prevent or slow down the progression of kidney diseases.

One of the groundbreaking aspects of his research was the discovery that the kidney itself synthesizes fibrinogen, a protein traditionally associated with blood clotting. Ajay demonstrated that a reduction in fibrinogen levels could protect against kidney injury, providing a new target for therapeutic intervention. Additionally, his work on STAT3 in pericytes revealed its role in kidney fibrosis, further contributing to the understanding of how chronic kidney disease develops.

Ajay has also contributed to cancer research, particularly in understanding how chemotherapeutic drugs induce molecular signaling in tumors. His work on p53, a crucial tumor suppressor protein, and its phosphorylation by cyclin-dependent kinase 5 (Cdk5) has provided insights into how cancer cells respond to chemotherapy, potentially leading to more effective treatment strategies.

Accolades and Recognition 🏆

Throughout his career, Ajay has received numerous awards and honors, reflecting the impact and significance of his research. He was honored with the Cardio-Renal Oral Presentation Award by the Department of Medicine at Brigham and Women’s Hospital in 2018, and he has received multiple best poster presentation awards from the Society of Toxicology. These accolades underscore his contributions to the fields of nephrology and toxicology.

His research excellence has also been recognized through prestigious grants and fellowships, including the CRISPR Innovation Award, which supports his ongoing work in gene editing to understand and potentially treat kidney fibrosis. His leadership in research is further evidenced by his successful mentorship of undergraduate students and postdoctoral fellows, who have gone on to make their own contributions to science.

Legacy and Future Contributions 🌟

Ajay’s work has had a profound impact on the understanding of kidney diseases and cancer biology. His research has not only advanced the scientific community’s knowledge but has also paved the way for the development of new therapeutic strategies that could improve patient outcomes. As he continues his work at Harvard Medical School, Ajay is poised to make further contributions to the field, particularly in the areas of epigenetics and the molecular mechanisms of disease progression.

Looking forward, Ajay’s research will likely continue to focus on the intersection of molecular biology and disease, with an emphasis on translating basic scientific discoveries into clinical applications. His ongoing projects, including those funded by the NIH and other prestigious organizations, are expected to yield new insights into the prevention and treatment of kidney diseases, thereby cementing his legacy as a leader in the field of nephrology and biomedical research.

Conclusion 🌐

Amrendra Ajay’s career is marked by a relentless pursuit of knowledge and a commitment to advancing the understanding of complex diseases. His contributions to nephrology, cancer research, and immunology have had a lasting impact on these fields. As he continues to explore new research avenues, Ajay’s work will undoubtedly lead to further scientific breakthroughs and innovations that could change the way we approach the treatment of chronic diseases.

🎓Publication 

Local vascular Klotho mediates diabetes-induced atherosclerosis via ERK1/2 and PI3-kinase-dependent signaling pathways

  • Authors   :Ajay, A.K., Zhu, L.-J., Zhao, L., … Shah, S.I., Hsiao, L.-L.
  • Journal    :Atherosclerosis
  • Year         :2024

TLR2 and TLR9 Blockade Using Specific Intrabodies Inhibits Inflammation-Mediated Pancreatic Cancer Cell Growth

  • Authors   :Ajay, A.K., Gasser, M., Hsiao, L.-L., Böldicke, T., Waaga-Gasser, A.M.
  • Journal    :Antibodies
  • Year         :2024

Survival, growth and digestive functions after exposure to nanodiamonds – Transgenerational effects beyond contact time in house cricket strains

  • Authors   :Augustyniak, M., Ajay, A.K., Kędziorski, A., … Wiśniewska, K., Ziętara, P.
  • Journal    :Chemosphere
  • Year         :2024

Personalized Therapeutics

  • Authors   :Peer, G.D.G., Saini, A., Vibhuti, A., Ajay, A..
  • Journal    :Nanotherapeutics for Inflammatory Arthritis: Design, Diagnosis, and Treatment,
  • Year         :2024

Putting transcriptional brakes on fibrosis: a negative regulator of TGFβ signaling

  • Authors   :Rohil, A., Talekar, S., Shammas, K.M., Ajay, A.K.
  • Journal    :Trends in Cell Biology
  • Year         :2024

Prof Dr. Birgit Lorenz|Ophthalmologie| Best Paper Award

Published on by Top Pharmaceutical

Prof Dr. Birgit Lorenz |Ophthalmologie|Best Paper Award|

Prof Dr. Birgit Lorenz at TransMIT Center of Translational Ophthalmology c/o Justus-Liebig, Germany

PROFILE  

scopus

Orcid

 

Early Academic Pursuits 🎓

Prof. Dr. med. Birgit Lorenz began her distinguished academic journey at the Ludwig-Maximilians-University in Munich, Germany. Her medical studies spanned from 1968 to 1974, with an enriching stint at the Sorbonne/Hôpital Cochin in Paris, France. Demonstrating academic excellence early on, she earned her MD thesis with the highest honors, summa cum laude, in Biochemistry from Ludwig-Maximilians-University in 1974. This solid foundation set the stage for a prolific career in ophthalmology and medical genetics.

Following her graduation, Prof. Lorenz pursued a residency in ophthalmology at the Department of Ophthalmology at Ludwig-Maximilians-University Munich, completing it between 1977 and 1982. During this time, she not only honed her clinical skills but also deepened her commitment to research, eventually leading to a PhD thesis (Habilitation) from the same institution in 1989. Her early academic endeavors also included a prestigious research fellowship at the Institute of Ophthalmology in London, where she worked with renowned institutions like Moorfields Eye Hospital and the Hospital for Sick Children.

Professional Endeavors 🏥

Prof. Lorenz’s professional career is marked by a series of significant appointments at prestigious institutions. Her journey began as a Fellow and Consultant in Ophthalmology at Ludwig-Maximilians-University Munich (1982-1991), where she built a reputation as a dedicated clinician and researcher. In 1991, she transitioned to the University of Regensburg, where she served as a Full Professor of Pediatric Ophthalmology, Strabismology, and Ophthalmic Genetics. Her tenure at Regensburg lasted until 2007, during which time she also led the Department of Pediatric Ophthalmology.

In 2007, Prof. Lorenz moved to Justus-Liebig University Giessen, taking on the role of Full Professor and Chairman of the Department of Ophthalmology. For over a decade, she spearheaded advancements in ophthalmic genetics and pediatric ophthalmology. Even after her official retirement, she continued her impactful work as a Professor Emeritus and Senior Clinical Expert for Inherited Retinal Degenerations at the University of Bonn (2020-2022). Currently, she directs the TransMIT Centre for Translational Ophthalmology at TransMIT GmbH, affiliated with Justus-Liebig-University Giessen.

Contributions and Research Focus 🔬

Throughout her illustrious career, Prof. Lorenz has made profound contributions to the fields of ophthalmic genetics, pediatric ophthalmology, and retinal degenerations. Her research has often focused on inherited retinal diseases (IRDs), with an emphasis on understanding their molecular underpinnings and developing potential gene therapies. A prime example of her work includes her involvement in a significant DFG-funded project on chromatic pupillometry, aimed at creating new biomarkers to quantify retinal function and assess the efficacy of gene therapies.

Prof. Lorenz has also been instrumental in several other groundbreaking projects, such as developing device-independent algorithms for enhanced optical coherence tomography (OCT) in retinal diseases and quantifying rod-and-cone function in X-linked retinal dystrophies. Her research has consistently been at the forefront of efforts to translate scientific discoveries into clinical applications, particularly in the realm of gene and cell-based therapies for neuroretinal degeneration.

Accolades and Recognition 🏆

Prof. Lorenz’s contributions to ophthalmology have been recognized with numerous awards and honors. She is a Fellow of the European Board of Ophthalmology (FEBO) and has received prestigious awards such as the Lifetime Achievement Award from the European Paediatric Ophthalmology Society (EPOS) and the Science Award from the Bielschowsky Society. Additionally, she has been elected as a member of esteemed organizations such as the Academia Ophthalmologica Internationalis (AOI) and the European Academy of Ophthalmology (EAO).

Her leadership in the field is also evident from her roles in various international organizations. She served as the President of the International Society of Genetic Eye Diseases and Retinoblastoma (ISGEDR) from 2016 to 2020 and has been an influential figure in the European Vision Institute Clinical Research Network (EVICR.net) and the German Ophthalmological Society (DOG).

Impact and Influence 🌍

Prof. Lorenz’s impact on the field of ophthalmology extends beyond her research and clinical work. She has been a key organizer of international meetings, bringing together experts to discuss the latest advancements in genetic eye diseases, pediatric ophthalmology, and retinal degenerations. Notable events she has organized include the Annual Meeting of the Société de Génétique Ophtalmologique Francophone and the Meeting of the International Society of Genetic Eye Diseases and Retinoblastoma.

Her influence is further reflected in her role as a reviewer for numerous peer-reviewed journals and as a member of editorial boards. She has also been a mentor to countless students and young researchers, shaping the future of ophthalmic genetics through her dedication to teaching and mentorship.

Legacy and Future Contributions 🧬

As Prof. Lorenz continues to contribute to the field through her work at the TransMIT Centre for Translational Ophthalmology, her legacy is one of pioneering research, clinical excellence, and unwavering commitment to advancing the understanding and treatment of genetic eye diseases. Her work has paved the way for future breakthroughs in gene therapy, and her influence will undoubtedly continue to inspire and guide new generations of ophthalmologists and researchers.

In the years to come, Prof. Lorenz’s contributions will likely expand as she remains actively involved in cutting-edge research and international collaborations. Her ongoing projects and the knowledge she imparts to her students and colleagues ensure that her impact on the field will endure for many years, shaping the future of ophthalmology and genetics.

🎓Publication 

Twelve-month Natural History Study of Centrosomal Protein 290 (CEP290)-associated Inherited Retinal Degeneration

  • Authors   :Pierce, E.A., Ashimatey, B.S., Jayasundera, T., … Myers, R., Pennesi, M.E..
  • Journal    :Ophthalmology Science.
  • Year         :2024

Treated Cases of Retinopathy of Prematurity in Germany: 10-Year Data from the Retina.net Retinopathy of Prematurity Registry

  • Authors   :Pfeil, J.M., Barth, T., Lagrèze, W.A., … Völker, M., Hagemann, U.
  • Journal    :Ophthalmology Retina
  • Year         :2024

Comparability of input parameters in the German Retina.net ROP registry and the EU-ROP registry – An exemplary comparison

  • Authors   :Winter, K., Pfeil, J.M., Engmann, H., … Bartmann, I.R., Stahl, A.
  • Journal    :Acta Ophthalmologica,
  • Year         :2024

Single Center Experience with Voretigene Neparvovec Gene Augmentation Therapy in RPE65 Mutation–Associated Inherited Retinal Degeneration in a Clinical Setting

Characterising the refractive error in paediatric patients with congenital stationary night blindness: a multicentre study

Prof Dr. Elaine Leung|Pharmacology | Best Researcher Award

Published on by Top Pharmaceutical

Prof Dr. Elaine Leung |Pharmacology|Best Researcher Award|

Prof Dr. Elaine Leung at Department of Biomedical Science, Faculty of Health Science, Macau

PROFILE  

scopus

 

Early Academic Pursuits 🎓

Elaine Lai-Han Leung embarked on her academic journey with a strong foundation in biological sciences, obtaining her BSc in Biology and Biochemistry from The Chinese University of Hong Kong in 2001. Her deep interest in biomedical sciences led her to pursue further studies, earning an MPhil in Biochemistry in 2003, followed by a PhD in Physiology in 2006 from the same institution. Her early academic pursuits laid the groundwork for a career marked by significant contributions to biomedical research, particularly in the fields of cancer biology and traditional Chinese medicine.

Professional Endeavors 🧬

Professor Leung’s professional career has been centered at the University of Macau, where she is a prominent figure in the Department of Biomedical Science, Faculty of Health Science. Over the years, she has established herself as a leading researcher, focusing on the intersection of modern biomedical sciences and traditional Chinese medicine. Her work has involved both academic research and collaborations with industry, where she has taken on numerous consultancy projects, contributing to the development of new therapies and drug discoveries.

Contributions and Research Focus 🔬

Professor Leung’s research is primarily focused on cancer biology, with an emphasis on non-small cell lung cancer (NSCLC). She has been the principal investigator (PI) or co-investigator (Co-I) on numerous research projects, many of which are aimed at understanding the mechanisms of drug resistance and the development of novel therapeutic strategies. Her ongoing research includes studies on KRAS resistance mechanisms, the role of gut microbiota in cancer immunomodulation, and the use of traditional Chinese medicine in treating various forms of cancer.

Some of her key projects include:

  • The relationship between KRAS resistance mechanisms and the immune microenvironment: An ongoing project at the University of Macau aimed at uncovering how KRAS mutations affect immune responses in cancer.
  • High-dimensional single-cell analysis of Sotorasib resistance clinical samples: This research seeks to identify new small molecule inhibitors for treating NSCLC.
  • Investigation of the anti-tumor effect of microbial valeric acid in NSCLC: Completed in 2023, this study explored how microbial byproducts can influence tumor immunity.

Accolades and Recognition 🏆

Professor Leung’s contributions to biomedical science have not gone unnoticed. She has been recognized with numerous awards and honors throughout her career, reflecting her standing in the scientific community. Her work has been cited extensively in leading scientific journals, with her citation index reflecting her influence in the fields of cancer biology and traditional Chinese medicine. Her collaboration with Nobel Laureate Erwin Neher on drug research further underscores her prominence in the field.

Impact and Influence 🌍

The impact of Professor Leung’s work extends beyond academia. Her research has significant implications for the development of new cancer therapies, particularly in the context of drug resistance. By bridging the gap between traditional Chinese medicine and modern biomedical research, she has opened new avenues for treatment that could benefit patients worldwide. Her work on gut microbiota and its role in cancer treatment, for instance, is pioneering in its approach and has the potential to revolutionize how cancer is treated.

Legacy and Future Contributions 🌟

As Professor Leung continues her work at the University of Macau, her legacy is already taking shape. She is helping to mentor the next generation of scientists while pushing the boundaries of what is possible in cancer research. Her ongoing projects, including those funded by significant grants, are expected to yield new insights into cancer biology and treatment. Looking ahead, her contributions will likely continue to influence the field of biomedical sciences, particularly in how traditional Chinese medicine is integrated into modern therapeutic strategies.

Research and Innovations 🧪

Completed/Ongoing Research Projects 📊

Professor Leung has completed numerous research projects, with many others ongoing. Her portfolio includes more than a dozen major projects, ranging from small-scale studies to large, collaborative efforts with industry partners. These projects have attracted significant funding, including:

  • Macao Science and Technology Development Fund (2021/2024): Investigating the combinational treatment effects of ginseng polysaccharides with immunotherapy in lung cancer, with a budget of USD 230,769.
  • Zhuhai UM Science and Technology Institute joint lab projects: Ongoing studies on drug resistance and immune microenvironment interactions in cancer, funded at approximately USD 641,000.

Citation Index 📚

Professor Leung’s work is highly regarded in the scientific community, as reflected by her citation index in databases such as Scopus and the Science Citation Index (SCI). Her research articles have been cited extensively, demonstrating the impact and relevance of her work in advancing biomedical science.

Consultancy/Industry Projects 🤝

Beyond academia, Professor Leung has engaged in several industry-sponsored projects, often serving as a consultant. These projects have allowed her to apply her research in practical settings, contributing to the development of new drugs and therapeutic strategies. Notably, she has collaborated with leading pharmaceutical companies like Janssen Pharmaceuticals, where her work on immunophenotyping in lung cancer patients has been highly influential.

Conclusion 🎯

Professor Elaine Lai-Han Leung’s career is a testament to the power of interdisciplinary research and collaboration. Her contributions to cancer biology, her innovative use of traditional Chinese medicine, and her commitment to bridging the gap between research and industry have made her a pivotal figure in her field. As she continues to explore new frontiers in biomedical science, her legacy will undoubtedly be one of lasting impact, shaping the future of cancer treatment and beyond.

🎓Publication 

Tanshinone IIA induces ER stress and JNK activation to inhibit tumor growth and enhance anti-PD-1 immunotherapy in non-small cell lung cancer

  • Authors   :Zhang, Y.-Z., Lai, H.-L., Huang, C., … Wu, Q.-B., Leung, E.L.-H.
  • Journal    :Phytomedicine
  • Year         :2024

Genome engineering of the human gut microbiome

MMP14high macrophages orchestrate progressive pulmonary fibrosis in SR-Ag-induced hypersensitivity pneumonitis

  • Authors   :Peng, D., Li, J., Li, Y., … Yang, P., Li, G.
  • Journal    :Pharmacological Research.
  • Year         :2024

Paris saponin VII reverses resistance to PARP inhibitors by regulating ovarian cancer tumor angiogenesis and glycolysis through the RORα/ECM1/VEGFR2 signaling axis

 

Ms. Nokubonga Zulu|Formulation Science | Best Researcher Award

Published on by Top Pharmaceutical

Ms. Nokubonga ZulFormulation Science |Best Researcher Award|

Ms. Nokubonga Zulu at Johannesburg,South Africa

PROFILE  

scopus

 

Early Academic Pursuits 🎓

Nokubonga Given Zulu’s journey into the field of metallurgy began with a strong academic foundation laid at the University of Johannesburg, one of South Africa’s leading institutions. She pursued a Bachelor of Engineering Technology (BEng Tech Hons) in Extraction Metallurgy, a rigorous program that provided her with the essential knowledge and skills required in the field. Nokubonga demonstrated exceptional dedication and discipline throughout her undergraduate studies, which culminated in her graduation. Her passion for metallurgy, coupled with her strong academic performance, set the stage for her future endeavors.

Following her undergraduate studies, Nokubonga continued to excel academically by enrolling in a Master of Engineering (MEng) degree in Extraction Metallurgy at the same university. She completed this program with distinction, a testament to her hard work and commitment to her field. Her master’s research focused on Biomining, particularly bioflotation, which is a cutting-edge area of study within metallurgical engineering. This research not only broadened her knowledge but also positioned her as a budding expert in the emerging field of biometallurgy.

Professional Endeavors 💼

Nokubonga’s professional journey began while she was still a student. She gained invaluable experience working in various roles at the University of Johannesburg, including as a Mineral Processing Lab Assistant and an Analytical Lab Assistant. These positions allowed her to develop a practical understanding of metallurgical processes and laboratory techniques. She also served as an Academic Tutor, where she helped students grasp complex concepts in process engineering, research methodology, and metallurgical projects. Her role as a Research Assistant further honed her skills in conducting experiments and contributing to academic research, which proved instrumental in her subsequent career.

In 2022, Nokubonga expanded her professional horizons by undertaking a three-month training program as a Trainee Metallurgist at the Kibali Gold Mine, operated by Barrick Gold Corporation in the Democratic Republic of Congo. This experience exposed her to real-world applications of mineral processing, hydrometallurgy, and pyrometallurgy. Working at one of the largest gold mines in Africa, Nokubonga deepened her understanding of the practical challenges faced in the industry, enhancing her critical thinking and problem-solving skills.

Currently, Nokubonga is working as a Graduate Metallurgist at Siyanda Bakgatla Platinum Mine. In this role, she is responsible for plant inspections and tracking process recipes based on day-to-day changes in the plant. This position allows her to apply her academic knowledge in a practical setting, contributing to the optimization and efficiency of metallurgical processes in the platinum mining sector.

Contributions and Research Focus 🔬

Nokubonga’s contributions to the field of metallurgy are noteworthy, particularly in the area of biomining. Her master’s research on bioflotation, a process that uses biological agents to separate valuable minerals from ores, has the potential to revolutionize the field by providing more sustainable and environmentally friendly methods of mineral extraction. This research has not only advanced the academic understanding of biomining but has also positioned Nokubonga as a leader in this niche field.

Her academic contributions include five published research outputs, comprising two journal articles and three conference papers. These publications reflect her deep engagement with the metallurgical community and her commitment to advancing knowledge in her field. Nokubonga’s work is currently under further review, indicating that she continues to push the boundaries of her research, with the potential for more significant contributions in the future.

Accolades and Recognition 🏆

Nokubonga’s academic excellence and professional achievements have not gone unnoticed. Completing her MEng degree with distinction is a significant accolade that underscores her dedication and expertise. While specific awards and recognitions are not detailed in the provided information, her progression from a student to a respected professional in the field is itself a testament to her capabilities and the recognition she has garnered within the academic and professional communities.

Impact and Influence 🌍

Nokubonga Given Zulu’s impact extends beyond her immediate academic and professional achievements. As a South African female in a traditionally male-dominated field, she serves as a role model and inspiration for other young women aspiring to enter the fields of engineering and metallurgy. Her dedication to acquiring knowledge and her pursuit of excellence have positioned her as a leader in her field, with the potential to influence future generations of metallurgists.

Her work in biomining, particularly bioflotation, has the potential to significantly impact the metallurgical industry by promoting more sustainable and environmentally friendly practices. This focus on innovation and sustainability aligns with global trends in mining and metallurgy, further enhancing her influence on the field.

Legacy and Future Contributions 🚀

Looking ahead, Nokubonga’s aspirations include pursuing a Ph.D. with a focus on Geometallurgy and Biometallurgy. This next step in her academic journey will allow her to further specialize in her areas of interest and contribute even more significantly to the field. Her ongoing research and future studies are expected to yield new insights and innovations, further solidifying her legacy as a pioneer in biomining.

Nokubonga’s legacy will be one of dedication, discipline, and a relentless pursuit of knowledge. As she continues to advance in her career, her contributions to both academia and industry are likely to leave a lasting impact on the field of metallurgy. Her journey serves as an inspiration to others, particularly young women, who aspire to make their mark in science and engineering.

Conclusion 🌟

Nokubonga Given Zulu is a shining example of what can be achieved through dedication, discipline, and a passion for learning. Her academic and professional journey reflects a commitment to excellence and a desire to make meaningful contributions to the field of metallurgy. As she continues to pursue her goals, her impact on the field and her legacy as a pioneering female metallurgist are set to grow, inspiring future generations to follow in her footsteps.

🎓Publication 

Optimization of Upper group 2 flotation using Acidithiobacillus ferrooxidans as a modifier

  • Authors   :Zulu, N.G., Thethwayo, B.M., Madiba, M.
  • Journal    :Minerals Engineering
  • Year         :2024

THERMODYNAMIC EFFECTS OF TEMPERATURE DURING ROASTING OF CHROMITE FOR SODIUM CHROMATE SALTS FORMATION

  • Authors   :Mvita, M.J., Zulu, N.G., Thethwayo, B., Makhamisa, S.
  • Journal    :MetalurgijaT
  • Year         :2024

Prof. Fatma YURT|pharmaceuticals | Best Researcher Award

Published on by Top Pharmaceutical

Prof. Fatma YURT |pharmaceuticals|Best Researcher Award|

Prof. Fatma YURT atEge University,Turkey

PROFILE  

scopus

Orcid

Early Academic Pursuits 🎓

Prof. Dr. Fatma Yurt’s journey into the scientific world began at Ege University, one of Turkey’s leading institutions. She completed her undergraduate studies at the Faculty of Science in the Department of Chemistry between 1982 and 1987. Her passion for science and dedication to learning set the stage for her illustrious career in nuclear sciences. Following her bachelor’s degree, she pursued a doctorate at Ege University in the Institute of Nuclear Sciences, specializing in Nuclear Sciences. From 1991 to 1998, she immersed herself in the study of nuclear applications, gaining a deep understanding of the field’s complexities and potential. This period of intense academic focus and research laid a solid foundation for her future contributions to nuclear medicine, radiopharmacy, and related fields.

Professional Endeavors 💼

Prof. Dr. Fatma Yurt’s professional career is marked by her steady rise through the academic ranks at Ege University. She began her career as a Research Assistant in the Nuclear Applications Department of the Institute of Nuclear Sciences, where she served from 1994 to 1997. This role allowed her to engage in cutting-edge research and contribute to the development of nuclear sciences in Turkey.

In 1999, she was promoted to Assistant Professor, and later in the same year, she achieved the rank of Associate Professor. Her commitment to education and research was evident as she continued to mentor students and lead research projects in nuclear applications. By 2007, she had earned the title of Professor, solidifying her position as a leading expert in her field.

Prof. Dr. Yurt’s expertise is not limited to academia; she has also held significant administrative roles. Since 2016, she has served as the Director of the Institute of Nuclear Sciences at Ege University. In this capacity, she has been instrumental in shaping the direction of nuclear research and education in Turkey, overseeing various projects and initiatives that have expanded the institute’s influence both nationally and internationally.

Contributions and Research Focus 🔬

Prof. Dr. Fatma Yurt’s research spans several critical areas within nuclear sciences, with a particular emphasis on nuclear medicine, radiopharmacy, and pharmacology. Her work in these fields has been pivotal in advancing the understanding and application of nuclear techniques in medicine, particularly in diagnosing and treating various diseases.

Her research contributions include the development of novel radiopharmaceuticals, which are essential for diagnosing and treating conditions such as cancer. Prof. Dr. Yurt’s expertise in nuclear chemistry and physical chemistry has enabled her to explore the intricate processes involved in the synthesis and application of these compounds. She has also contributed significantly to the field of health sciences, particularly in the areas of internal medicine and pharmaceutical technology.

With a Scopus publication count of 123 and a Unisis publication count of 296, Prof. Dr. Yurt’s research output is impressive. Her work has been cited over 1,447 times on Scopus, reflecting the impact and relevance of her research. Her H-Index, a measure of both the productivity and citation impact of her publications, stands at 21 on Scopus, further underscoring her influence in the field.

Accolades and Recognition 🏆

Throughout her career, Prof. Dr. Fatma Yurt has received numerous accolades and recognition for her contributions to nuclear sciences and medicine. Her research has been widely acknowledged by her peers, and she has been invited to present her findings at various national and international conferences. Her role as the Director of the Institute of Nuclear Sciences is a testament to her leadership abilities and her dedication to advancing the field of nuclear applications.

Prof. Dr. Yurt’s work has not only advanced scientific understanding but has also had a tangible impact on healthcare. Her contributions to radiopharmacy have been particularly significant, with her research playing a crucial role in the development of new diagnostic and therapeutic methods. Her dedication to her field is further demonstrated by her ongoing involvement in academic mentorship, helping to train the next generation of scientists in nuclear sciences.

Impact and Influence 🌍

Prof. Dr. Yurt’s influence extends beyond her research and academic roles. As a leader in nuclear sciences, she has been instrumental in promoting the importance of nuclear applications in medicine and other fields. Her work has helped to bridge the gap between basic research and practical applications, ensuring that the benefits of nuclear science are realized in clinical settings.

Her leadership at the Institute of Nuclear Sciences has also been pivotal in shaping the research agenda in Turkey, encouraging interdisciplinary collaboration and fostering a culture of innovation. Under her guidance, the institute has strengthened its position as a center of excellence in nuclear research, attracting students and researchers from around the world.

Legacy and Future Contributions 🌟

Prof. Dr. Fatma Yurt’s legacy is one of dedication, innovation, and leadership. Her contributions to nuclear medicine, radiopharmacy, and related fields have had a lasting impact on both the scientific community and the broader healthcare sector. As she continues her work, her influence will undoubtedly grow, inspiring new research and leading to further advancements in nuclear applications.

🎓Publication 

An in vitro evaluation of Hypericum perforatum loaded-chitosan nanoparticle/agarose film as a Wound dressing

Unveiling combat strategies against Candida spp. biofilm structures: Demonstration of photodynamic inactivation with innovative phthalocyanine derivatives

Platinum (II) Schiff Base Complexes and their Effects on the Inhibition of Amyloid β1–42 Aggregation

In Vitro Assessment of 177Lu-Labeled Trastuzumab-Targeted Mesoporous Carbon@Silica Nanostructure for the Treatment of HER2-Positive Breast Cancer

  • Authors   :Tunçel, A., Maschauer, S., Prante, O., Yurt, F.
  • Journal    :Pharmaceuticals
  • Year         :2024